Multifunctional Au Modified Ti 3 C 2 -MXene for Photothermal/Enzyme Dynamic/Immune Synergistic Therapy
Abstract
Ti 3 C 2 -MXene-based composites provide multifunctional interfaces in diagnosis and treatment of tumors. Herein, we proposed a multifunctional nanoplatform based on Ti 3 C 2 -MXene–Au nanocomposites, which combines photothermal properties and peroxidase-like activity, accomplishing synergistic photothermal therapy (PTT) and enzyme dynamic therapy (EDT) accompanied by photoacoustic (PA) and thermal dual-mode imaging in vivo . Furthermore, PTT induces immunogenic cell death, and EDT promotes cell apoptosis, facilitating dendritic cell (DC) maturation and T cell infiltration into the tumor. On this basis, the antibody OX40 (αOX40) was utilized to further contribute immune therapy for reversing the immunosuppressive tumor microenvironment by activating CD4 + and CD8 + T cells. In summary, a triune of PTT/EDT/antitumor immune therapy is achieved by combining Ti 3 C 2 -MXene–Au nanocomposites and αOX40, which possesses several strong features of good biocompatibility, NIR-controlled targeting, significant cancer cell killing, and satisfactory biosafety in vitro and in vivo . Our work might highlight the promising application of MXene-based nanoplatforms for cancer therapy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Chang et al. proposed a multifunctional nano platform based on Ti3C2-MXene Au nanocomposite, which realized the triune of PTT/Enzyme kinetics therapy/antitumor immune therapy, and accompanied by photoacoustic (PA) and thermal dual-mode imaging in vivo.
“Chang et al. proposed a multifunctional nano platform based on Ti3C2-MXene Au nanocomposite, which realized the triune of PTT/Enzyme kinetics therapy/antitumor immune therapy, and accompanied by photoacoustic (PA) and thermal dual-mode imaging in vivo.87”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [87]
Cites
Two‐Dimensional Nanocrystals Produced by Exfoliation of Ti 3 AlC 2
Naguib, M., Kurtoglu, M., Presser, V., Lu, J., Niu, J., Heon, M., Hultman, L., Gogotsi, Y. G., & Barsoum, M. W. (2011) · Advanced Materials · doi:10.1002/adma.201102306 · Cited by 11,947 · see citing works
Gold Nanoparticles in Chemical and Biological Sensing
Saha, K., Agasti, S. S., Kim, C., Li, X., & Rotello, V. M. (2012) · Chemical Reviews · doi:10.1021/cr2001178 · Cited by 4,637 · see citing works
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Boisselier, É., & Astruc, D. (2009) · Chemical Society Reviews · doi:10.1039/b806051g · Cited by 2,832 · see citing works
Photodynamic therapy and anti-tumour immunity
Castaño, A. P., Mróz, P., & Hamblin, M. R. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1894 · Cited by 2,685 · see citing works
Functional Nanomaterials for Phototherapies of Cancer
Cheng, L., Wang, C., Feng, L., Yang, K., & Liu, Z. (2014) · Chemical Reviews · doi:10.1021/cr400532z · Cited by 2,432 · see citing works
PD-L1 Expression in Triple-Negative Breast Cancer
Mittendorf, E. A., Philips, A. V., Meric‐Bernstam, F., Qiao, N., Wu, Y., Harrington, S. M., Su, X., Wang, Y., Gonzalez-Angulo, A. M., Akçakanat, A., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0127 · Cited by 1,394 · see citing works
Self-citationTwo-dimensional transition metal carbides and nitrides (MXenes) for biomedical applications
Huang, K., Li, Z., Lin, J., et al. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00838d · Cited by 1,104 · see citing works
Liu, G., Zou, J., Tang, Q., Yang, X., Zhang, Y., Zhang, Q., Huang, W., Chen, P., Shao, J., & Dong, X. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b13421 · Cited by 693 · see citing works
Gold Nanorods: The Most Versatile Plasmonic Nanoparticles
Zheng, J., Cheng, X., Zhang, H., Bai, X., Ai, R., Shao, L., & Wang, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00422 · Cited by 660 · see citing works
Han, X., Huang, J., Lin, H., Wang, Z., Li, P., & Chen, Y. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701394 · Cited by 511 · see citing works
Nano‐Gold as Artificial Enzymes: Hidden Talents
Lin, Y., Ren, J., & Qu, X. (2014) · Advanced Materials · doi:10.1002/adma.201400238 · Cited by 481 · see citing works
Tay, Z. W., Chandrasekharan, P., Chiu-Lam, A., Hensley, D. W., Dhavalikar, R., Zhou, X. Y., Yu, E. Y., Goodwill, P. W., Zheng, B., Rinaldi, C., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b00893 · Cited by 459 · see citing works
Orangi, J., Hamade, F., Davis, V. A., & Beidaghi, M. (2019) · ACS Nano · doi:10.1021/acsnano.9b07325 · Cited by 445 · see citing works
Zheng, P., Ding, B., Jiang, Z., Xu, W., Li, G., Ding, J., & Chen, X. (2021) · Nano Letters · doi:10.1021/acs.nanolett.0c04778 · Cited by 360 · see citing works
Gold Nanozymes: From Concept to Biomedical Applications
Lou-Franco, J., Das, B., Elliott, C. T., & Cao, C. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-00532-z · Cited by 333 · see citing works
Tang, W., Dong, Z., Zhang, R., Yi, X., Yang, K., Jin, M., Yuan, C., Xiao, Z., Liu, Z., & Cheng, L. (2018) · ACS Nano · doi:10.1021/acsnano.8b05982 · Cited by 317 · see citing works
Rationale for anti-OX40 cancer immunotherapy
Aspeslagh, S., Postel-Vinay, S. C., Rusakiewicz, S., Soria, J., Zitvogel, L., & Marabelle, A. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.08.021 · Cited by 316 · see citing works
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
Riera-Domingo, C., Audigé, A., Granja, S., Cheng, W.-C., Ho, P.-C., Baltazar, F., Stockmann, C., & Mazzone, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00018.2019 · Cited by 310 · see citing works
Cancer Cell Targeting Using Multiple Aptamers Conjugated on Nanorods
Huang, Y., Chang, H., & Tan, W. (2008) · Analytical Chemistry · doi:10.1021/ac702322j · Cited by 303 · see citing works
Biology and Management of Patients With Triple-Negative Breast Cancer
Sharma, P. (2016) · The Oncologist · doi:10.1634/theoncologist.2016-0067 · Cited by 294 · see citing works
Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy
Zhang, J. C., Lin, Y., Lin, Z. R., Wei, Q., Qian, J., Ruan, R., Jiang, X., Hou, L., Song, J., Ding, J., et al. (2021) · Advanced Science · doi:10.1002/advs.202103444 · Cited by 293 · see citing works
Ultrasmall gold nanoparticles in cancer diagnosis and therapy
Fan, M., Han, Y., Gao, S., Yan, H., Cao, L., Li, Z., Liang, X., & Zhang, J. (2020) · Theranostics · doi:10.7150/thno.42471 · Cited by 278 · see citing works
Determination of peak positions and areas from wide‐scan XPS spectra
Turner, N. H., & Single, A. M. (1990) · Surface and Interface Analysis · doi:10.1002/sia.740150305 · Cited by 272 · see citing works
Zhao, Y., Sun, Y., Zhang, Y., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b09282 · Cited by 255 · see citing works
2D Ti2C (MXene) as a novel highly efficient and selective agent for photothermal therapy
Szuplewska, A., Kulpińska, D., Dybko, A., et al. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.01.021 · Cited by 248 · see citing works
Jiang, X., Zhang, S., Ren, F. Z., Chen, L., Zeng, J., Zhu, M., Cheng, Z., Gao, M., & Li, Z. (2017) · ACS Nano · doi:10.1021/acsnano.7b01032 · Cited by 206 · see citing works
Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
Gao, J., Wang, W.-Q., Pei, Q., Lord, M. S., & Yu, H.-J. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0400-z · Cited by 203 · see citing works
Gao, A., Chen, B., Gao, J., Zhou, F., Saeed, M., Hou, B., Li, Y., & Yu, H. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b04012 · Cited by 198 · see citing works
Self-citationNear-infrared inorganic nanomaterial-based nanosystems for photothermal therapy
Wang, Y., Meng, H., & Li, Z. (2021) · Nanoscale · doi:10.1039/d1nr00323b · Cited by 183 · see citing works
The pro-tumorigenic host response to cancer therapies
Shaked, Y. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0209-6 · Cited by 181 · see citing works
Li, Z., Xu, W., Yang, J.-Z., Wang, J., Wang, J., Zhu, G., Li, D., Ding, J., & Sun, T. (2022) · Advanced Materials · doi:10.1002/adma.202200449 · Cited by 181 · see citing works
Boron Dipyrromethene Nano‐Photosensitizers for Anticancer Phototherapies
Sun, W. C., Zhao, X., Fan, J., Du, J., & Peng, X. (2019) · Small · doi:10.1002/smll.201804927 · Cited by 178 · see citing works
Liu, Y., Yáng, Z., Huang, X., Yu, G., Wang, S., Zhou, Z., Shen, Z., Fan, W., Liu, Y., Davisson, M., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b02980 · Cited by 156 · see citing works
The Role of Tumor-Associated Macrophages in Colorectal Carcinoma Progression
Zhong, X., Chen, B., & Yang, Z. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000486816 · Cited by 148 · see citing works
Sun, W. Y., Du, Y., Liang, X., Yu, C., Fang, J., Lü, W., Guo, X., Tian, J., Jin, Y., & Zheng, J. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119264 · Cited by 138 · see citing works
Li, Y., Kang, Z., Kong, L., et al. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110000 · Cited by 137 · see citing works
Self-citationEngineering Prodrug Nanomedicine for Cancer Immunotherapy
Yang, B., Gao, J., Pei, Q., Xu, H., & Yu, H. (2020) · Advanced Science · doi:10.1002/advs.202002365 · Cited by 115 · see citing works
Xue, G., Jin, G., Fang, J., & Lu, Y. (2019) · Nature Communications · doi:10.1038/s41467-019-09401-9 · Cited by 108 · see citing works
Hu, X., Hou, B., Xu, Z., Saeed, M., Sun, F. Z., Gao, Z., Lai, Y., Zhu, T., Zhang, F., Zhang, W., et al. (2020) · Advanced Science · doi:10.1002/advs.201903332 · Cited by 103 · see citing works
Zhang, X., Cheng, L., Lu, Y., Tang, J., Lv, Q., Chen, X., Chen, Y., & Liu, J. (2021) · Nano-Micro Letters · doi:10.1007/s40820-021-00761-w · Cited by 94 · see citing works
The Electronic Structure of Some Palladium Alloys Studied by ESCA and X-ray Spectroscopy
Hedman, J., Klasson, M., Nilsson, R., et al. (1971) · Physica Scripta · doi:10.1088/0031-8949/4/4-5/008 · Cited by 93 · see citing works
Calcium ion nanomodulators for mitochondria-targeted multimodal cancer therapy
Zheng, P., & Ding, J. (2021) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2021.10.004 · Cited by 73 · see citing works
Jeong, S. K., Kim, J., Lee, C. G., Park, Y.-S., Kim, S., Yoon, S. O., Han, D. H., Lee, K. Y., Jeong, M. H., & Jo, W. S. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.11.010 · Cited by 58 · see citing works
Wu, J., Lu, Y., Wu, Z., Li, S., Zhang, Q. Y., Chen, Z., Jiang, J., Lin, S., Zhu, L., Li, C., et al. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.01.166 · Cited by 47 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073 · see citing works
- Authors
- Chang, X., Wu, Q., Wu, Y., Xi, X., Cao, J., Chu, H., Liu, Q., Li, Y., Wu, W., Fang, X., & Chen, F.
- Affiliations
- Jilin University (CN)
- Key Laboratory of Pathobiology, Ministry of Education, Nanomedicine and Translational Research Center, China-Japan Union Hospital of Jilin University, 126 Sendai Street, Changchun, 130033 Jilin, China
- Corresponding author
- Fang, Xuedong
- Chen, Fangfang
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2022-10-12
- Volume
- 22
- Issue
- 20
- Pages
- 8321-8330
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W4304692003
- Cited by
- 109
- References
- 44
- Citations by year
- 2026: 19 · 2025: 36 · 2024: 29 · 2023: 24 · 2022: 1
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nano Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Natural Science Foundation of Jilin Province (YDZJ202101ZYTS024)
- Ministry of Science and Technology of the People's Republic of China (2021YFC2400600, 2021YFC2400603)
- China Postdoctoral Science Foundation (2022TQ0118)
- National Natural Science Foundation of China (32271446)
- Jilin Department of Health (2018SCZ005)
- Norman Bethune Program of Jilin University (2022B21, 2022B37)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Materials Chemistry › MXene and MAX Phase Materials
- Physical Sciences › Materials Science › Materials Chemistry › Advanced Nanomaterials in Catalysis
- Keywords
- Ti3C2 MXene, gold nanocomposites, photothermal therapy, peroxidase-like activity, photoacoustic imaging, infrared thermography, immunogenic cell death, dendritic cell maturation, T cell infiltration, cancer immunotherapy, immunosuppressive tumor microenvironment
- MeSH terms
- Photothermal Therapy, Humans, Neoplasms, Peroxidases, Phototherapy, Titanium, CD8-Positive T-Lymphocytes, Cell Line, Tumor, Nanoparticles, Nanocomposites, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review